-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RUTI in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RUTI in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drug Details: RUTI is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Pyelonephritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Pyelonephritis Drug Details: PF-06947387 (aztreonam in combination with avibactam) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MBK-001 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MBK-001 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: MBK-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Urinary Tract Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Urinary Tract Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Gram-Negative Bacterial Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Gram-Negative Bacterial Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Complicated Intra-Abdominal Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Complicated Intra-Abdominal Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Peritonitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Peritonitis Drug Details: PF-06947387 (aztreonam in combination with avibactam) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Bacterial Pneumonia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Bacterial Pneumonia Drug Details: PF-06947387 (aztreonam in combination with avibactam) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Ventilator Associated Pneumonia (VAP)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Ventilator Associated Pneumonia (VAP) Drug Details: PF-06947387 (aztreonam in combination with...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP) Drug Details: PF-06947387 (aztreonam in combination with...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.